Have you missed any webinars from 2018? You can watch the recordings here! All webinars are free of charge.

See what webinars are coming up

View our most highly-rated webcasts from previous years

Diabetes: Multifaceted Approaches to Address Adherence, Cost, and Improved Outcomes

Diabetes is the leading cost driver for clients, accounting for more than 10% of total drug expenditures, and these numbers continue to rise as the diabetes epidemic continues.  Diabetes is the most expensive therapy class in traditional drug spending, and higher than specialty therapeutic classes such as oncology, multiple sclerosis, and HIV.  Adherence rates for diabetes medications continue to be less than optimal, and overall hemoglobin A1c does not appear to be trending down despite increases in drugs and costs.

This webinar discusses a multifaceted approach on how to manage spend via different utilization management strategies, identify and address adherence issues from a global perspective, improve clinical pathway selections, and increase patient engagement to drive clinical outcomes. 

Patty Taddei-Allen, PharmD, BCACP, BCGP, Director, Outcomes Research, WellDyneRx
Nick Page, PharmD, Vice President, Specialty and Clinical Operations, WellDyneRx

View the webcast

Are You Ready to Comply with 455? How the CMS Regulation Affects You.

A 2015 report estimates that approximately $60 billion of American tax money, or more than 10% of Medicare’s total budget, was lost to fraud, waste, abuse and improper payments in 2014.

Centers for Medicare and Medicaid Services’ (CMS) strategy for ridding the system of fraud has been to move away from a pay-and-chase system to a preventive model. Identifying high-risk providers on the front end is easier than tracking and unraveling complicated transactions on the back end.

To help reduce the risk of fraud, waste and abuse, CMS has established requirements for Medicaid programs to validate their networks. All Medicaid PBMs, especially Managed Medicaid PBMs, may bear the brunt of this risk assessment.

This webinar explores the new CMS regulation, the impact on PBMs, and how PBMs can use data, analytics and advanced technology to be in compliance.

Learning objectives:
  • Understand the scope of the 455 regulations as it relates to PBMs
  • Explore the kinds of data available to screen and validate providers
  • Evaluate data solutions to comply with 455 requirements and network validation
Bobbie Riley, RPh, Director, Pharmacy, LexisNexis Risk Solutions
Brian Eidex, Director, Pharmacy, LexisNexis Risk Solutions

View the webcast

Findings from PBMI's 2018 Trends in Specialty Drug Benefits Report

Did you know that 58% of plan sponsors use coinsurance for member cost sharing over copayments?  Employers continue to look for creative ways to battle the growing cost of specialty drug trend while continuing to offer quality benefits for their employees.

Listen to this webcast to learn more about this strategy and many others employers are using to manage their specialty drug benefits.

Report and webinar sponsored by Walgreens and AllianceRx Walgreens Prime.

View the webcast

Impacting Drug Trend: Spend Less, Get More

Analytics and patient engagement strategies are the foundation to understanding, building, and executing strategies to decrease drug spend and improve quality.

During this webinar, Michael T. Einodshofer, Chief Innovation Officer, Maxor Plus, examines these strategies and how they can be used to deliver a drug trend guarantee for clients.

Learning objectives:
  • Learn about innovative clinical strategies and formulary/benefit designs that decrease drug trend
  • Understand how clinical strategies and PBM savings can be bundled together into a “guarantee”
  • Apply examples to a case study that illustrates a drug trend guarantee
View the webcast
* By registering for a webinar, you are authorizing PBMI to send you emails about future webinars.  You may unsubscribe at any time.